Qiming U.S. Ventures Management

Latest statistics and disclosures from Qiming U.S. Ventures Management's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are TRML, KRRO, JSPR, KZR, and represent 100.00% of Qiming U.S. Ventures Management's stock portfolio.
  • Reduced shares in these 2 stocks: VTYX, Hillevax.
  • Sold out of its positions in Hillevax, VTYX.
  • Qiming U.S. Ventures Management was a net seller of stock by $-1.6M.
  • Qiming U.S. Ventures Management has $56M in assets under management (AUM), dropping by 135.59%.
  • Central Index Key (CIK): 0001909617

Tip: Access up to 7 years of quarterly data

Positions held by Qiming U.S. Ventures Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Qiming U.S. Ventures Management

Qiming U.S. Ventures Management holds 4 positions in its portfolio as reported in the September 2025 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Tourmaline Bio (TRML) 63.8 $36M 742k 47.83
 View chart
Korro Bio (KRRO) 31.7 $18M 368k 47.89
 View chart
Jasper Therapeutics Com New (JSPR) 4.0 $2.2M 929k 2.38
 View chart
Kezar Life Sciences Com New (KZR) 0.6 $323k 83k 3.90
 View chart

Past Filings by Qiming U.S. Ventures Management

SEC 13F filings are viewable for Qiming U.S. Ventures Management going back to 2021